Yet, despite the numerous clinical studies showing positive on weight loss and sports performance, there is also an equal number of studies, showing inconclusive or contradictory results
On Health Systems In a world where people are regularly taking a GLP-1, our healthcare system looks very different
FDA regulates the manufacturing of mass-manufactured drugs, including brand-name semaglutide drugs
Energy and Motivation May Fluctuate Some patients report: Increased fatigue Irritability Mental distraction Decreased enthusiasm for routine habits These symptoms often relate to changes in appetite hormones and blood sugar stability
They understand that: side effects are real benefits can also be real medical supervision matters muscle preservation must be intentional stopping should be planned, not guessed cost and access are part of the decision medication works best inside a broader health strategy That is the whole truth
Dysesthesia signal (Phase 3) TRIUMPH-4 topline results, released December 11, 2025, reported dysesthesia in about 20.9% of participants at the highest dose